Laurel Wealth Advisors, Inc. Bristol Myers Squibb CO Transaction History

Laurel Wealth Advisors, Inc.

$1.01 Billion
Q4 2022

A detailed history of Laurel Wealth Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 15,230 shares of BMY stock, worth $878,466. This represents 0.11% of its overall portfolio holdings.

Number of Shares

15,230

Previous 15,256 0.17%

Holding current value

$878,466

Previous $1.09 Million 1.01%

% of portfolio

0.11%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $1,780 - $2,108	-26 Reduced 0.17%	15,230 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $2 - $1,459	19 Added 0.12%	15,256 $1.09 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $25,780 - $28,392	-355 Reduced 2.28%	15,237 $1.17 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $23,055 - $27,645	-375 Reduced 2.35%	15,592 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $267,828 - $312,224	4,994 Added 45.51%	15,967 $996,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $9,881 - $11,574	-167 Reduced 1.5%	10,973 $649,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $866 - $943	14 Added 0.13%	11,140 $745,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $37,918 - $42,646	-639 Reduced 5.43%	11,126 $702,000
Q4 2020 Mar 03, 2021	SELL	$57.74 - $65.43 $3,348 - $3,794	-58 Reduced 0.49%	11,765 $730,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $1,033 - $1,145	-18 Reduced 0.15%	11,823 $712,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $1,918 - $2,243	-35 Reduced 0.29%	11,841 $696,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1,392 - $2,022	-30 Reduced 0.25%	11,876 $662,000
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $275,477 - $359,335	-5,598 Reduced 31.98%	11,906 $765,000
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $353,408 - $419,016	8,263 Added 89.42%	17,504 $887,000
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $64,208 - $71,000	1,439 Added 18.44%	9,241 $419,000
Q1 2019 May 16, 2019	BUY	$45.12 - $53.8 $7,489 - $8,930	166 Added 2.17%	7,802 $372,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $40,178 - $52,101	-824 Reduced 9.74%	7,636 $396,000
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $14,680 - $16,558	266 Added 3.25%	8,460 $525,000
Q2 2018 Aug 20, 2018	BUY	$50.53 - $62.98 $12,127 - $15,115	240 Added 3.02%	8,194 $453,000
Q1 2018 May 16, 2018	BUY	$59.92 - $68.98 $44,640 - $51,390	745 Added 10.33%	7,954 $503,000
Q4 2017 Feb 15, 2018	BUY	$59.94 - $65.35 $53,406 - $58,226	891 Added 14.1%	7,209 $441,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $220 - $254	4 Added 0.06%	6,318 $402,000
Q2 2017 Aug 15, 2017	BUY	N/A	6,314	6,314 $351,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.

Account

Laurel Wealth Advisors, Inc. Bristol Myers Squibb CO Transaction History